Skip to main content
Journal cover image

EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS

Publication ,  Conference
Thompson, E; Landi, D; Ashley, D; Keir, S; Bigner, D
Published in: Neuro-Oncology
November 5, 2018

Duke Scholars

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 5, 2018

Volume

20

Issue

suppl_6

Start / End Page

vi102 / vi102

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Thompson, E., Landi, D., Ashley, D., Keir, S., & Bigner, D. (2018). EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS. In Neuro-Oncology (Vol. 20, pp. vi102–vi102). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noy148.426
Thompson, Eric, Daniel Landi, David Ashley, Steve Keir, and Darell Bigner. “EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS.” In Neuro-Oncology, 20:vi102–vi102. Oxford University Press (OUP), 2018. https://doi.org/10.1093/neuonc/noy148.426.
Thompson E, Landi D, Ashley D, Keir S, Bigner D. EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS. In: Neuro-Oncology. Oxford University Press (OUP); 2018. p. vi102–vi102.
Thompson, Eric, et al. “EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS.” Neuro-Oncology, vol. 20, no. suppl_6, Oxford University Press (OUP), 2018, pp. vi102–vi102. Crossref, doi:10.1093/neuonc/noy148.426.
Thompson E, Landi D, Ashley D, Keir S, Bigner D. EXTH-79. BEVACIZUMAB, IRINOTECAN, TEMOZOLOMIDE, TYROSINE KINASE INHIBITION, AND MEK INHIBITION ARE EFFECTIVE AGAINST PLEOMORPHIC XANTHOASTROCYTOMA REGARDLESS OF V600E STATUS. Neuro-Oncology. Oxford University Press (OUP); 2018. p. vi102–vi102.
Journal cover image

Published In

Neuro-Oncology

DOI

EISSN

1523-5866

ISSN

1522-8517

Publication Date

November 5, 2018

Volume

20

Issue

suppl_6

Start / End Page

vi102 / vi102

Publisher

Oxford University Press (OUP)

Related Subject Headings

  • Oncology & Carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1109 Neurosciences